What does Caris test for?
What does Caris test for?
Caris Molecular Intelligence performs comprehensive molecular testing on the DNA, RNA and Proteins to identify the biomarkers driving a patient’s tumor. This information may be a powerful tool to aid oncologists in personalizing cancer therapies for their patients.
What kind of company is Caris Life Sciences?
Caris Life Sciences® (Caris) is a molecular science company developing and delivering technologies to revolutionize healthcare.
What is Caris care?
Personalized Cancer Care with Molecular Profiling The first of its kind, Caris Molecular Intelligence is a unique tool that combines comprehensive tumor testing with the latest clinical research on biomarkers to provide your doctor with timely information to evaluate potential treatment options.
What is Caris MPI?
Caris provides cancer patients and oncologists with reliable, high-quality, comprehensive molecular information to deliver on the promise of precision medicine.
Is Caris CLIA certified?
Along with ISO 15189 accreditation, Caris has also earned accreditation from Clinical Laboratory Improvement Amendments (CLIA), as well as an extensive list of certifications from the state of New York.
What is Caris MI profile?
MI Profile is a multi-platform, solid tumor biomarker analysis for therapeutic decision support and clinical trials matching.
Who owns Caris?
Norman McRae
Founder. Norman McRae, founder of Caris Healthcare, has more than 30 years of experience in hospice care.
Who owns Caris Life?
Chairman and Chief Executive Officer David D. Halbert is a proven leader with a strong track record of growth and value creation in the energy, financial and healthcare industries. With more than 40 years of experience, Mr. Halbert continues to be one of the most successful entrepreneurs in this country.
Does Caris offer liquid biopsy?
“We are excited to partner with ESSA to expand the reach of Caris’ best-in-class liquid biopsy offering, assessing all 22,000 genes in both DNA and RNA, which are unique to an individual’s cancer,” said Brian Lamon, Chief Business Officer at Caris Life Sciences.
Is Mi profile FDA approved?
IRVING, Texas, May 3, 2019 – Caris Life Sciences®, a leading innovator in molecular science focused on precision medicine, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation for the company’s MI Transcriptome™ companion diagnostic (CDx) test.
Where is Caris Life Sciences located?
Irving, Texas
Headquartered in Irving, Texas, Caris Life Sciences offers services throughout the U.S., Europe, Asia and other international markets.
When was Caris founded?
2008
Founded in 2008, Caris Life Sciences® is on a mission to help patients, clinicians, researchers, and payors navigate, advance and reinvent cancer care.
